Beijing Konruns Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.028x

Beijing Konruns Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Beijing Konruns Pharmaceutical Co Ltd (603590) has a cash flow conversion efficiency ratio of 0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥96.44 Million ≈ $14.11 Million USD) by net assets (CN¥3.49 Billion ≈ $509.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Beijing Konruns Pharmaceutical Co Ltd (2013–2025)

Cash flow conversion efficiency of Beijing Konruns Pharmaceutical Co Ltd from 2013 to 2025. This chart illustrates how Beijing Konruns Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Beijing Konruns Pharmaceutical Co Ltd (603590) stock price for real-time trading data and today's change.

Beijing Konruns Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Beijing Konruns Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Beijing Konruns Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Konruns Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see 603590 market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
UEM Sunrise Bhd KLSE:5148	0.007x
TPI POLENE POWER BK:TPIPP-R	0.008x
CREOTECH INS.S.A. ZY -10 F:5OB	-0.259x
Merida Industry Co Ltd TW:9914	-0.009x
Sundiro Holding Co Ltd SHE:000571	-0.031x
Foosung KO:093370	-0.023x
Spearhead Integrated Marketing SHE:300071	-0.011x
Barco NV BR:BAR	-0.029x

Annual Cash Flow Conversion Efficiency for Beijing Konruns Pharmaceutical Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Beijing Konruns Pharmaceutical Co Ltd from 2013 to 2025. Review Beijing Konruns Pharmaceutical Co Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.50 Billion ≈ $511.65 Million	CN¥115.68 Million ≈ $16.93 Million	0.033x	-34.19%
2024-12-31	CN¥3.43 Billion ≈ $501.36 Million	CN¥172.25 Million ≈ $25.20 Million	0.050x	-15.21%
2023-12-31	CN¥3.36 Billion ≈ $492.02 Million	CN¥199.35 Million ≈ $29.17 Million	0.059x	+58.03%
2022-12-31	CN¥3.19 Billion ≈ $466.82 Million	CN¥119.69 Million ≈ $17.51 Million	0.038x	+65.64%
2021-12-31	CN¥3.13 Billion ≈ $458.10 Million	CN¥70.91 Million ≈ $10.38 Million	0.023x	+19.61%
2020-12-31	CN¥3.08 Billion ≈ $451.28 Million	CN¥58.41 Million ≈ $8.55 Million	0.019x	-80.28%
2019-12-31	CN¥2.73 Billion ≈ $399.19 Million	CN¥262.00 Million ≈ $38.34 Million	0.096x	-9.45%
2018-12-31	CN¥2.48 Billion ≈ $363.01 Million	CN¥263.11 Million ≈ $38.50 Million	0.106x	-46.86%
2017-12-31	CN¥1.36 Billion ≈ $198.32 Million	CN¥270.49 Million ≈ $39.58 Million	0.200x	+17.77%
2016-12-31	CN¥874.92 Million ≈ $128.03 Million	CN¥148.26 Million ≈ $21.70 Million	0.169x	-39.63%
2015-12-31	CN¥683.27 Million ≈ $99.98 Million	CN¥191.80 Million ≈ $28.07 Million	0.281x	+4.59%
2014-12-31	CN¥488.02 Million ≈ $71.41 Million	CN¥130.98 Million ≈ $19.17 Million	0.268x	-48.62%
2013-12-31	CN¥313.45 Million ≈ $45.87 Million	CN¥163.72 Million ≈ $23.96 Million	0.522x	--

About Beijing Konruns Pharmaceutical Co Ltd

SHG:603590 China Biotechnology

Market Cap

$596.83 Million

CN¥4.08 Billion CNY

Market Cap Rank

#11000 Global

#3019 in China

Share Price

CN¥25.65

Change (1 day)

-0.89%

52-Week Range

CN¥24.54 - CN¥47.42

All Time High

CN¥65.00